[1] DU Y, HUANG R. Research on the core competitiveness of pharmaceutical listed companies based on fuzzy comprehensive evaluation[J]. Journal of Intelligent & Fuzzy Systems, 2020, 38(6): 6971-6978 [2] PILLAIYAR T, MEENAKSHISUNDARAM S, MANICKAM M, et al. A medicinal chemistry perspective of drug repositioning: recent advances and challenges in drug discovery[J]. European Journal of Medicinal Chemistry, 2020, 195: 112-275 [3] 李亚林, 来小鹏. 美国药品专利保护期延长制度研究[J]. 中国新药杂志, 2020, 29(4): 361-366 LI Yalin, LAI Xiaopeng. Study on patent term extension of U. S. A[J]. Chinese Journal of New Drugs, 2020, 29(4): 361-366 [4] NERLOVE M, ARROW K J. Optimal advertising policy under dynamic conditions[J]. Economica, 1962, 29(114): 129-142 [5] RAHMAN M, RODRÍGUEZ-SERRANO Á, LAMBKIN M. Advertising efficiency and profitability: evidence from the pharmaceutical industry[J]. Industrial Marketing Management, 2020, 89: 619-629 [6] ZHANG J, CHEN B, XIE J. Benefits of bilateral participation in cooperative advertising[J]. Journal of the Operational Research Society, 2021, 72(2): 281-291 [7] HASSAN B, GUIOMAR M, SIHEM T. Could myopic pricing be a strategic choice in marketing channels? A game theoretic analysis[J]. Journal of Economic Dynamics & Control, 2009, 33(9): 1699-1718 [8] CHIANG W K. Supply chain dynamics and channel efficiency in durable product pricing and distribution[J]. Manufacturing & Service Operations Management, 2012, 14(2): 327-343 [9] LU F, LIU G, ZHANG J, et al. Benefits of partial myopia in a durable product supply chain considering pricing and advertising[J]. Journal of the Operational Research Society, 2016, 67(10): 1309-1324 [10] LIU G, SETHI S P, ZHANG J. Myopic vs. far-sighted behaviours in a revenue-sharing supply chain with reference quality effects[J]. International Journal of Production Research, 2016, 54(5): 1334-1357 [11] LIU Y, ZHANG J, ZHANG S, et al. Prisoner's dilemma on behavioral choices in the presence of sticky prices: farsightedness vs. myopia[J]. International Journal of Production Economics, 2017, 191: 128-142 [12] CURTIS A, MCVAY S, TOYNBEE S. The changing implications of research and development expenditures for future profitability[J]. Review of Accouting Studies, 2020, 25(2): 405-437 [13] PARRA A. Sequential innovation, patent policy, and the dynamics of the replacement effect[J]. Journal of Economics, 2019, 50(3): 568-590 [14] 张新鑫, 侯文华, 申成霖. 价格管制、医保支付政策与制药企业创新激励[J]. 科研管理, 2015, 36(12): 120-128 ZHANG Xinxin, HOU Wenhua, SHEN Chenglin. Price regulation, medicare payment policy and pharmaceutical firm's innovation incentives[J]. Science Research Management, 2015, 36(12): 120-128 [15] 张新鑫, 侯文华, 申成霖, 等. 集中采购参与意愿、制药企业议价能力与药品市场绩效[J]. 中国管理科学, 2017, 25(7): 113-122 ZHANG Xinxin, HOU Wenhua, SHEN Chenglin, et al. Willingness to participate in group procurement, pharmaceutical enterprises' bargaining power and performance of medicine market[J]. Chinese Journal of Management Science, 2017, 25(7): 113-122 [16] 张新鑫, 侯文华, 申成霖. 价格管制、战略性创新激励与创新药市场绩效[J]. 科研管理, 2017, 38(10): 68-75 ZHANG Xinxin, HOU Wenhua, SHEN Chenglin. Price regulation, strategic innovation incentives and pharmaceutical market performance[J]. Science Research Management, 2017, 38(10): 68-75 [17] ZHANG J, GOU Q, LI S, et al. Cooperative advertising with accrual rate in a dynamic supply chain[J]. Dynamic Games and Applications, 2017, 7(1): 112-130 [18] CHUTANI A, SETHI S P. Dynamic cooperative advertising under manufacturer and retailer level competition[J]. European Journal of Operational Research, 2018, 268(2): 635-652 [19] 刘欣艺, 张银丹. 基于制造商-销售商供应链双向补贴博弈研究[J]. 工业工程, 2018, 21(6): 64-71,90 LIU Xinyi, ZHANG Yindan. A research on the two-way subsidy game based on manufacturer-seller supply chain[J]. Industrial Engineering Journal, 2018, 21(6): 64-71,90 [20] MA S, HE Y, GU R, et al. Feedback equilibrium for dynamic competitive and cooperative advertising[J]. Procedia Computer Science, 2019, 159: 1843-1852
|